US$ 25.72
tirzepatide 6 month supply Oral | Starts at $279/mo Tirzepatide – Apex Telehealth Clinic
Description
Individual Dose

A newly published study from researchers at Lilly found greater weight loss with tirzepatide than semaglutide among adults treated for obesity in routine clinical practice

Alzheimers Dement J Alzheimers Assoc

The SELECT trial recently showed semaglutide reduces MACE by 20 percent even in nondiabetic patients with cardiovascular disease

ZepBound, launched for obesity in late 2023, quickly added hundreds of millions in sales by mid-2025, its global sales were already in the hundreds of millions as clinics rolled out the new weight-loss injection
